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Available online 16 November 2016Campylobacter jejuni is the leading cause of bacterial gastroenteritis in theworld. A number of factors are believed
to contribute to the ability of C. jejuni to cause disease within the human host including the secretion of non-ﬂa-
gellar proteins via the ﬂagellar type III secretion system (FT3SS). Here for the ﬁrst time we have utilised quanti-
tative proteomics using stable isotope labelling by amino acids in cell culture (SILAC), and label-free liquid
chromatography-mass spectrometry (LC/MS), to compare supernatant samples from C. jejuni M1 wild type
and ﬂagella-deﬁcient (ﬂgG mutant) strains to identify putative novel proteins secreted via the FT3SS. Genes
encoding proteins that were candidates for ﬂagellar secretion, derived from the LC/MS and SILAC datasets,
were deleted. Infection of human CACO-2 tissue culture cells using these mutants resulted in the identiﬁcation
of novel genes required for interactions with these cells. This work has shown for the ﬁrst time that both
CJM1_0791 and CJM1_0395 are dependent on the ﬂagellum for their presence in supernatants from C. jejuni
stains M1 and 81–176.
Biological signiﬁcance: This study provides themost complete description of theCampylobac er jejuni secretome to
date. SILAC and label-free proteomics comparing mutants with or without ﬂagella have resulted in the identiﬁ-
cation of two C. jejuni proteins that are dependent on ﬂagella for their export from the bacterial cell.nary Med
Kingdom.
cal Center
. This is an© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Mass spec1. Introduction
Campylobacter jejuni is the leading cause of foodborne bacterial gas-
troenteritis in the world [1]. Cases of C. jejuni infection are most com-
monly acute and self-limiting in healthy individuals, however a
number of complications can occur post-infection. The most serious of
these is the development of Guillian-Barré syndrome, an acute demye-
linating disease resulting in progressive ascending paralysis [2].
Research investigating C. jejuni pathogenesis has identiﬁed impor-
tant roles for ﬂagellum-dependent motility, adhesion/invasion of host
epithelial cells and toxin production among others, as factors important
for causing human disease [3]. Although these factors are frequently ob-
served among bacterial pathogens, C. jejuni appears unlike other enteric
pathogens with respect to extracellular protein secretion [4].
It has been proposed that C. jejuni utilises its ﬂagellum not only for
motility but also to act as a conduit for the secretion of non-ﬂagellar pro-
teins [5]. Previous studies have identiﬁedmultiple components of the C.icine, University of
and the University of
open access article underjejuni ﬂagellum that are required for the export of the Campylobacter in-
vasion antigens (Cia), and other non-ﬂagellar proteins, some of which
have been implicated in the ability of C. jejuni to invade human intesti-
nal cell lines [6–17]. CiaBwas theﬁrst non-ﬂagellar C. jejuni protein pro-
posed to be dependent upon the ﬂagellum for secretion, and is required
for efﬁcient invasion of INT-407 cells [9]. CiaB is also suggested to be re-
quired for the secretion of at least two other proteins, CiaC and CiaI [7,9,
11,12]. CiaC and CiaI secretion requires a minimum ﬂagellar structure
containing the hook protein FlgE [7,11,12]. CiaC is necessary for wild
type invasion of INT-407 cells [7]. A ciaImutant of C. jejuni F38011 dis-
plays reduced survival within INT-407 cells, while a ciaI mutant of C.
jejuni 81–176 is reduced in its ability to colonize the chicken intestinal
tract [11,12]. Another Cia protein that is dependent on the ﬂagellum
for secretion, CiaD, is also required for maximal invasion of INT-407
cells [13,14]. Furthermore, FlaC and FspA also require aminimumﬂagel-
lar structure for extracellular secretion [15,16]. FlaC, which has high se-
quence similarity to the major and minor ﬂagellin ﬁlaments of C. jejuni,
binds Hep-2 cells, and a C. jejuni TGH9011 ﬂaCmutant is reduced in its
ability to invade those cells [15]. FspA is readily observed as two iso-
forms among different C. jejuni isolates, and the external addition of
FspA2 induces apoptosis of INT-407 cells [16]. Another study has identi-
ﬁed a group of proteins dependent on σ28 for their production and se-
cretion and hence that are expressed under the same conditions asthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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co-expressed determinants). This group of four proteins is required for
colonization of chickens, with FedA also important for invasion of
human-derived T84 cells [12].
Although multiple C. jejuni proteins are dependent on the ﬂagellum
for their secretion, a possible mechanism by which it might interact
with host cells has yet to be described. Moreover, the ability of a C. jejuni
strain 81–176 ciaBmutant to invade T84 cells is not statistically different
from the wild type [17]. Much of the literature describing non-ﬂagellar
protein secretion via the C. jejuni ﬂagellum has documented proteins
secreted to the extracellular environment. The biological relevance of
this for effector-like proteins is unclear, as they are likely to be subjected
to degradation by host proteases. There has also been no identiﬁcation of
a conserved amino acid sequence present among non-ﬂagellar C. jejuni
proteins that might act as a ﬂagellar secretion signal, as has been
described for the Yersinia enterocolitica protein YplA [18].
In this studywe have used a combination of SILAC (stable isotope la-
belling by amino acids in cell culture) and label-free LC-MS (liquid chro-
matography-mass spectrometry) to investigate the C. jejuni ﬂagellum-
dependant secretome. This has enabled a comprehensive screen of the
C. jejuni secretome, in an attempt to identify previously undescribed
proteins, both ﬂagellar and non-ﬂagellar, being transported via the C.
jejuni ﬂagellar type III secretion apparatus (FT3SS). Utilizing C. jejuni
stain M1 is a suitable strain for this purpose as it has been documented
to colonize both human and avian hosts [19]. Therefore, in using strain
M1 we hope to comprehensively assess ﬂagella-dependent proteins,
possibly contributing to colonization of chickens and/or the develop-
ment of human disease.
2. Materials and methods
2.1. Bacterial strains and culture conditions
All wild type strains and deﬁned mutants are described in Table S1.
C. jejuni strains were routinely cultured on Brain Heart Infusion (BHI,
Oxoid) agar plates supplemented with 5% deﬁbrinated horse blood
(Oxoid) and 5 μg/ml trimethoprim (TrM). Strains containing FLAG-
tagged proteins were grown in the presence of 50 μg/ml kanamycin
(Km). Gene deletion mutants were grown in the presence of 10 μg/ml
chloramphenicol (Cm). FLAG-tagged strains also containing gene dele-
tions were grown in the presence of 50 μg/ml Km and 10 μg/ml Cm.
Microaerophilic conditions for C. jejuni growth (5% O2, 10% CO2 and
85% N2) were maintained by a MACS VA500 variable atmosphere
work station (Don Whitley Scientiﬁc).
2.2. Isotopic labelling of C. jejuni cultures
C. jejuni strain M1 and its isogenic ﬂgG mutant were grown on 1%
SILAC DMEM plates supplemented with 10 mM L-Glutamine (Sigma)
and either L-Arginine-HCL (Thermo Fisher Scientiﬁc) or L-Arginine
13C6, 15N4 (Thermo Fisher Scientiﬁc). Powdered SILAC DMEM (Thermo
Fisher Scientiﬁc) was dissolved in water to create a 2× SILAC DMEM so-
lution. Amounts of either L-Arginine-HCL or L-Arginine 13C6, 15N4 were
added to the solution, dissolved, and passed through a 0.22 μm ﬁlter.
To this, an equal volume of sterile 2% select agar (Sigma) was added
and supplemented with 10 mM L-Glutamine. For validation of the
SILAC data by Western immunoblotting, 1% DMEM plates were com-
posed of 2× standard DMEM (Millipore) mixed with 2% sterile agar as
above, and supplemented with 10 mM L-Glutamine. Bacterial strains
were streaked on relevant media from frozen stocks and incubated at
42 °C under microaerophilic conditions for 48 h.
2.3. Preparation of C. jejuni supernatants
For SILAC labelled cultures, once isotopic amino acid incorporation
was achieved a previously published protocol for the generation of C.jejuni supernatants [6,12] was utilised, adapted here for use with
DMEM. Bacteria were suspended to an OD600nm of 0.6 in 20mls SILAC
DMEM (Thermo Fisher Scientiﬁc) supplemented with a relevant
amount of “light” (wild type samples) or “heavy” (mutant samples) L-
Arginine, and 10 mM L-Glutamine. This 20 ml culture was overlaid
onto 5 ml 1% SILAC DMEM agar and was incubated statically at 42 °C
under microaerophilic conditions for 4 h. Various growth experiments
revealed that these conditions were optimal for C. jejuni growth in
DMEM (data not shown). For the M1 ﬂgG mutant, chloramphenicol
was added at a concentration of 10 μg/ml to both 1%DMEMagar and liq-
uid SILAC DMEM. At the end of the incubation period, OD600nm mea-
surements were taken for each culture, and 1 ml of each culture was
pelleted for subsequent whole cell protein sample preparation. Each re-
maining 18ml culturewas centrifuged at 4000×g for 20min, the super-
natant was transferred to a fresh tube and the centrifugation step was
repeated. Supernatants were then passed through a syringe with a
0.22 μm ﬁlter to remove any remaining whole bacteria. Following this,
15 ml of each supernatant was transferred to an Amicon Ultra centrifu-
gal ﬁlter unit (Millipore) and centrifuged at 4000 g for 30min. To make
supernatant samples for SILAC validation experiments, the above proto-
col was followed using 1% standard DMEM agar (Gibco) supplemented
with 10 mM L-Glutamine. Concentrated supernatant samples were di-
vided into aliquots which were stored at−20 °C for future use.
2.4. LC-MS/MS analysis
The unlabelled, or SILAC labelled samples were reduced with tris(2-
carboxyethyl) phosphine (TCEP) then alkylated with iodoacetamide
(Sigma) followed by digestion by trypsin (Thermo Fisher Scientiﬁc)
overnight at 37 °C. 0.5 μg (unlabelled samples) or 1.5 μg (SILAC samples)
of the digest were submitted for the nano LC-MS/MS analyses on an Ul-
timate 3000 RSLCnano System coupled to a LTQ Orbitrap Velos hybrid
mass spectrometer equipped with a nanospray source. The peptides
were ﬁrst loaded and desalted on a PepMap C18 trap column (100 μm
id × 20 mm, 5 μm) then separated on a PepMap C18 analytical column
(75 μm id × 500 mm, 2 μm) over a 90 min (unlabelled samples) or
180 min (SILAC labelled samples) linear gradient of 4–32% CH3CN/
0.1% formic acid (the HPLC, mass spectrometer and columns were all
from Thermo Fisher Scientiﬁc). The Orbitrap mass spectrometer was
operated in the standard “top 15 or top 10” data-dependant acquisition
modes while the preview mode was disabled. The MS full scan was set
at m/z 380–1600 with the resolution at 30,000 at m/z 400 and AGC at
1 × 106 with a maximum injection time at 200 msec. The 15, or 10,
most abundant multiply-charged precursor ions, with a minimal signal
above 3000 counts, were dynamically selected for CID fragmentation
(MS/MS) in the ion trap, which had the AGC set at 5000 with the max-
imum injection time at 100msec. The dynamic exclusion duration time
was set for 60 s with ±10 ppm exclusion mass width.
The raw ﬁles were processed in MaxQuant (Version 1.5.2.8, www.
MaxQuant.org) for both protein identiﬁcation and protein quantiﬁca-
tion. The C. jejuni M1 protein database was a combination of those
downloaded from UniprotKB (www.uniprot.org) of 11,168 (April
2015) andM1 (February 2015). Parameters usedweremainly in default
valueswith somemodiﬁcations: trypsinwithmaximum2missed cleav-
age sites, peptide mass tolerance at ﬁrst search was set at 20 ppm and
main search was at 4.5 ppm, MS/MS fragment mass tolerance at
0.50 Da, and top 8 MS/MS peaks per 100 Da and a minimum peptide
length of 7 amino acids were required. Fixed modiﬁcation for
Carbamidomethyl and variable modiﬁcation for Acetyl (Protein N-
term), Deamidated (NQ) and Oxidation (M) were used. False discovery
rates (FDR) were estimated based on matches to reversed sequences in
the concatenated target-decoy database. The maximum FDR at 1% was
allowed for proteins and peptide spectrum matches (PSMs). Peptides
were assigned to protein groups, a cluster of a leading protein(s) plus
additional proteins matching to a subset of the same peptides. For pro-
tein quantiﬁcation, the minimum ratio of two, from ‘unique and razor
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tween runs was disabled. The protein FDR was set to 0.1%. The
MaxQuant output was processed using Perseus (Version 1.5.2.6 www.
MaxQuant.org). Protein groups that are only identiﬁed by site, or re-
versematches and potential contaminants. Are ﬁltered out. A log2 trans-
formation of SILAC ratio was carried out, rowswere ﬁltered to contain a
minimum of two values and ﬁltered using a Benjamini-Hochberg FDR
test to 0.05. The SILAC data is provided in Table S2, the label-free LC/
MS data is provided in Table S3.2.5. Immunoblotting
Proteins were run on 4–12% SDS polyacrylamide gels, and subse-
quently transferred to PVDF membranes at 100 V for one hour. All
blocking steps were carried out shaking at 30 rpm using 3% fat-free
skimmed milk. Primary monoclonal anti-FLAG M2 antibody
(Sigma) was used at a concentration of 1:1000. Secondary goat
anti-mouse IgG-HRP (Santa Cruz Biotechnology) was used at a
concentration of 1:5000. Primary and secondary antibodies were
diluted in 3% fat-free skimmed milk. Washing steps were carried
out with PBS containing 0.05% Tween 20, and bands were detected
using Super Signal West Pico chemiluminescent substrate (Thermo
Fisher Scientiﬁc).2.6. Generation of deﬁned gene deletion mutants and FLAG-tagged
constructs
Construction of gene deletion mutants was carried out by allelic re-
placement as previously described [20], with each gene of interest being
replaced with a chloramphenicol resistance cassette (cat). Primer se-
quences are provided in Table S4. The cat cassette was ampliﬁed from
plasmid pCC027 [21] while 5′ and 3′ ﬂanking regions for each gene of
interest were ampliﬁed from C. jejuni strain M1 genomic DNA. Primers
used to amplify the 5′ and 3′ ﬂanking regions also contained overlap-
ping sequence for the cat cassette allowing this to be inserted between
the desired 5′ and 3′ sequences by primer-less PCR ampliﬁcation to cre-
ate a 5′ ﬂank-cat cassette-3′ ﬂank product. This product was used as a
template to amplify the desired sequence for allelic replacement by
electroporation, using the forward primer for 5′ ﬂank ampliﬁcation
and the reverse primer for 3′ ﬂank ampliﬁcation. Electroporation and
subsequent natural transformation was carried out as described previ-
ously [20], resulting in transformation of C. jejuni strainM1 and the gen-
eration of a coupled wild type strain.
FLAG-tagged proteins of interest were generated in C. jejuniM1 and
C. jejuni 81–176 by allelic replacement using a kanamycin resistance
cassette. Ampliﬁcation of the kanamycin cassette was carried out
using plasmid pRY107 [22] as a template, while ﬂanking regions were
ampliﬁed using as template genomic DNA from either C. jejuni M1 or
C. jejuni 81–176, genomic DNA. For each FLAG-tagged construct, a 5′
ﬂanking region was ampliﬁed consisting of ~400 bp upstream and an
ORF of interest with the FLAG sequence incorporated immediately be-
fore the stop codon. The reverse primer for the 5′ ﬂanking region also
contained overlapping sequence with the kanamycin resistance cas-
sette. The 3′ ﬂanking region consisted of ~400 bp downstream of the
ORF of interest with the forward primer containing an overlapping se-
quence with the kanamycin resistance cassette. As above for gene dele-
tion, primer-less PCR ampliﬁcation was carried out to combine a 5′
ﬂank-kanamycin cassette-3′ ﬂank product. This product, containing
the kanamycin resistance cassette, was then used to PCR amplify the de-
sired sequence for allelic replacement, by using the forward primer for
the 5′ ﬂank ampliﬁcation and the reverse primer from the 3′ ﬂank am-
pliﬁcation. Electroporation and natural transformation for native FLAG-
tag incorporation was carried out as described for the creation of de-
ﬁned gene deletions [20].2.7. Motility assay
C. jejuniwas grown on BHI blood agar plates for ~48 h then re-plated
on BHI blood plates for ~16 h. Suspensions of C. jejuni scraped from
plates into BHI were diluted to OD600nm of ~0.5 and were used to stab
motility plates comprised of BHI broth containing 0.4% select agar
(Sigma). Motility plates were incubated for ~16 h, following which the
diameter of the zone of motility was measured (n = 3).
2.8. Culture of CACO-2 cells
CACO-2 cell lineswere purchased from theATCC (CC-L244, HTB-37).
Cells were grown usingDMEM (Gibco) supplementedwith 10% FBS and
1% non-essential amino acids. Cells were routinely grown in 75 cm2 tis-
sue culture ﬂasks and incubated at 37 °C with 5% CO2 in a humidiﬁed
atmosphere.
2.9. CACO-2 cell infection assays
CACO-2 cellswere seeded at 2 × 105 cells on 12well plates (Greiner)
until conﬂuency was observed. CACO-2 cells were infected with differ-
ent C. jejuni strains at a multiplicity of infection of 100. To assay adher-
ence/invasion, infected cells were incubated with 5% CO2 in a
humidiﬁed atmosphere for 2 h. At this point non-adherent bacteria
were removed, subjected to 10-fold serial dilutions and plated on BHI
blood agar plates with 5 μg/ml TrM. Wells were washed three times
with PBS, and cells were lysed with 0.1% Triton-X-100 in PBS for
15 min. Lysed cells were subjected to 10-fold serial dilutions and plated
on BHI blood agar plates with 5 μg/ml TrM. To determine the number of
internalized bacteria, infected CACO-2 cells were incubated at 37 °C
with 5%CO2 in a humidiﬁed atmosphere. After 2 h, themediumoverlay-
ing the infected cells was changed to complete DMEM containing
250 μg/ml gentamycin sulphate and infected cells were incubated
with 5% CO2 in a humidiﬁed atmosphere for a further 2 h. Cells were
then washed three times with PBS and lysed with 0.1% Triton X-100 in
PBS for 15 min. Serial dilutions of the cell lysates were carried out and
plated on BHI blood agar plates with 5 μg/ml TrM. Dilutions of mutant
C. jejuni strains were plated on BHI blood agar plates containing 10 μg/
ml chloramphenicol. All plates were incubated for 48 h under
microaerophilic conditions at 42 °C before colony counting took place.
For both total association and invasion experiments, the percentage of
C. jejuni interacting with CACO-2 cells was calculated as a percentage
of the non-adherent fraction, to account for potentially different surviv-
al proﬁles of different strains in DMEM (n = 3).
3. Results
3.1. The C. jejuniM1 FT3SS-dependent secretome, as deﬁned by quantitative
proteomics
We designed a quantitative proteomics experiment utilizing SILAC
to screen proteins whose secretion from C. jejuni strain M1 may be me-
diated by the FT3SS (Fig. 1). To inhibit ﬂagellar secretion an isogeneic
M1 ﬂgG mutant was generated. C. jejuni strains with a disrupted ﬂgG
gene are inhibited in their secretion of several proteins via the FT3SS
[6]. The vast majority of proteins identiﬁed by SILAC analysis were sim-
ilarly abundant inWT and ﬂgG supernatants (Fig. 2), with similar obser-
vations having been described for Escherichia coli and Salmonella
enterica SILAC secretome screens [23,24]. Proteins possessing H/L ratios
lower than−2 (H =mutant labelled with “heavy” L-arginine, L =WT
labelled with “light” L-arginine) from SILAC analysis are shown in Table
1. Unsurprisingly, these comprised proteins associated with ﬂagellar
gene regulation or structure (FlgM, FlaG), but also FlaC, CiaC,
CJM_1572 and CJM1_0369. A number of proteins were found at an in-
creased abundance within ﬂgG supernatants. Proteins possessing the
highest H/L ratios largely represented factors that accommodate correct
Fig. 1. Overview of M1 secretome analysis. After isotopic incorporation of C. jejuniM1WT
and ﬂgG strains with either “light” or “heavy” arginine, respectively, (H=mutant labelled
with “heavy” L-arginine, L = WT labelled with “light” arginine), bacterial cells were
pelleted and supernatants were ﬁltered, pooled and concentrated. After digestion,
tryptic peptides were analysed by LC-MS/MS. Proteins secreted via the ﬂagellum are
characterized by enrichment of peptides containing “light” isotopes.
Table 1
Proteins with the H/L ratios below−2 (H = labelled mutant, L =
labelled WT) from the SILAC screen. Values included are the mean
from four biological replicates.
Ratio H/L normalized Description
−5.22125 FlaG
−4.90379 CiaC
−4.76184 FlgF
−3.93479 FlgI
−3.83989 CJM1_1572
−2.514 FliD
−2.23358 CJM1_0369
−2.11747 FlaC
184 E. Scanlan et al. / Journal of Proteomics 152 (2017) 181–187ﬂagellar assembly (Fig. 2). To increase the proteome coverage, and also
account for potential incomplete incorporation of “heavy” or “light” ar-
ginine in the mutant or WT, proteomic analysis of unlabelled M1 ﬂgG
and WT supernatants was also performed. Proteins detected within
the supernatant of M1 WT but not within ﬂgG supernatants are shownFig. 2.Mean H/L ratios of proteins detected in culture supernatants from four biological replicat
while high H/L are proteins found at increased abundance within ﬂgG supernatants.in Table 2. From the SILAC and unlabelled LC/MS data, 5 proteins were
chosen for further investigation (CiaI, FlaC, FspA, CJM1_0791 and
CJM1_0395). These proteins represented non-ﬂagellar proteins, none
of which has been characterized in strain M1, that were present at con-
trasting abundance within WT and ﬂgG supernatants.
3.2. FLAG-tagging of protein validates MS datasets
A number of the proteins selected for further investigation were
FLAG-tagged and assessed for their presence in supernatants obtained
fromM1WTand ﬂgG strains. As shown in Fig. 3, CiaI and FlaCwere pres-
ent in the concentrated supernatants from both M1 WT and ﬂgG, al-
though at a very reduced level from the ﬂgG mutant. CJM1_0791 and
CJM1_0395 were present only within M1WT supernatants, conﬁrming
the data obtained by label-free LC/MS. Analysis of CysM was included
for FLAG-tagging as it has previously been used as a marker for cell
lysis [13]. Surprisingly CysM was readily detected within supernatant
samples isolated from both M1WT and ﬂgGwithin the SILAC data.
3.3. Deﬁned gene deletion mutants alter the interaction of C. jejuni with
CACO-2 cells
Individual isogenic deletionmutants of M1were generated that lack
ciaI, ﬂaC, fspA, CJM1_0791 and CJM1_0395were generated. The abilities
of these mutants to interact with CACO-2 cells were measured. Rates
of growth and motility for each of the mutants were consistent withes. Low H/L ratios represent proteins found at a lower abundancewithin ﬂgG supernatants
Table 2
Proteins identiﬁedwithinM1WT supernatants thatwere absent inM1 ﬂgGmutant super-
natants as detected by standard LC/MS.
Razor + unique
peptides WT
Razor + unique
peptides ﬂgG
Q-value Description
9 0 0 Uncharacterized protein
CJM1_1572
8 0 0 Uncharacterized protein
CJM1_0791
7 0 0 CiaI
6 0 0 FspA
4 0 0 Uncharacterized protein
CJM1_0395
3 0 0 Uncharacterized protein
CJM1_0821
3 0 0 Uncharacterized protein
CJM1_1598
2 0 0 PurD
2 0 0 MutS
2 0 0 RplT
2 0 0 CmeE
2 0 0 IspH
2 0 0 FlgG
2 0 0 FtsZ
2 0 0 PseA
2 0 0 FliE
2 0 0 FlgB
185E. Scanlan et al. / Journal of Proteomics 152 (2017) 181–187that of theWT (Fig. S1). Fig. 4 shows the interaction for each strain with
CACO-2 cells, represented as a percentage of the coupledM1WT CACO-
2 cell interaction. Each of the mutants, except ciaI, adhered less well
than the WT. There was a statistically signiﬁcant difference in invasion
of each of the mutants except for ciaI and fspA. Disruption of M1 genes
ﬂaC and CJM1_0791 resulted inmore severe defects for adhesion and in-
vasion than that observed for fspA and CJM1_0395.
3.4. C. jejuni strain 81–176 CJM1_0791 and CJM1_0395 genes are depen-
dent on the ﬂagellum for translocation to the supernatant
To investigate whether the absence of CJM1_0791 (CJJ81176_0835)
and CJM1_0395 (CJJ81776_0441) within M1 ﬂgG supernatants was
strain-speciﬁc, these proteins were FLAG-tagged in C. jejuni 81–176
WT and 81–176 ﬂgG backgrounds. The CiaI and CysM protein equiva-
lents were also FLAG-tagged. As shown in Fig. 5, CJJ81176_0441 (equiv-
alent to CJM1_0395) was absent from the 81–176 ﬂgG supernatant,
consistent with data from M1. A very low level of CJJ81176_0835Fig. 3.Western blotting of FLAG-tagged proteins secreted from M1 WT and ﬂgG strains
identiﬁed at various H/L ratios within the SILAC experiment. Detection of FLAG-tag
incorporated into C-terminus of proteins of interest. Immunoblotting exhibits the effect
of an ﬂgG mutant on protein abundance within supernatant and whole cell protein
samples.(equivalent to CJM1_0791) was detected within the ﬂgG supernatant,
although there was a much higher abundance of the protein within
the 81–176 WT supernatant. Furthermore, CiaI was present at a much
higher level within theWT supernatant although still detectable within
the ﬂgGmutant supernatant, while CysM was readily detectible within
the supernatants from both strains.4. Discussion
The mechanisms by which C. jejuni invades human intestinal cell
lines without a dedicated system for the secretion of effector proteins
associatedwith virulence remains unknown, and is among themost im-
portant subjects for study regarding C. jejuni pathogenesis. Previous
studies have made good progress in identifying the C. jejuni ﬂagellum
as an organelle that mediates extracellular secretion of non-ﬂagellar
proteins. Some of these secreted proteins have been proposed to con-
tribute to the invasion of human cell lines by C. jejuni [5–15]. In this
study we have used a combination of SILAC and label-free LC/MS to
screen C. jejuni secretomes obtained from WT M1 and ﬂagellum-deﬁ-
cient strains.
SILAC analysis measuring the relative abundances of proteins from
M1WT and ﬂgG supernatants revealed that most proteinswere present
at a relatively equal abundance within supernatants from the WT and
ﬂgG mutant (Fig. 2). Similar observations have been made for SILAC
secretome studies using S. enterica and E. coli in the past [23,24]. Of
the proteins that scored the lowest H/L ratios, the presence of CiaI and
FlaC adds further support to existing evidence for their proposed
utilisation of the ﬂagellum as a mechanism of extracellular secretion
[11,15]. It was also observed that CiaI was secreted from M1WT when
analysed by label-free LC-MS. The role of the ﬂagellum in CiaI and FlaC
secretion was further conﬁrmed by FLAG-tagged CiaI and FlaC being
present at reduced levels (as detected byWestern blotting using an an-
tibody against the FLAG-tag) in ﬂgG mutant supernatants (Fig. 3 and
Fig. 5). The reduced abundance of FlaC in ﬂgG supernatants is in agree-
ment with the M1 SILAC data; this has not been observed in previous
studies [11,15]. Infection assays revealed no apparent inﬂuence of CiaI
on the ability of M1 to adhere to or invade CACO-2 cells. Disruption of
ﬂaC appeared to reduce levels of both M1 adherence and invasion of
CACO-2 cells (Fig. 4). For CiaI this is at odds with what has been de-
scribed regarding invasion using ciaI mutants in strains 81–176 and
F38011 [11,12]. It may be that either M1 ciaI does not display the
same phenotype as in 81–176 or F38011, or that a reduced interaction
for any C. jejuni ciaI mutant does not occur for CACO-2 cells as it does
for T84 cells. Previously it has been described that ﬂaC disruption re-
duces Hep-2 cell invasion by C. jejuni TGH9011 but does not alter adher-
ence [15], as it does in M1. Further work is required to establish the
function of FlaC across multiple C. jejuni strains, and its role during C.
jejuni pathogenesis. It is also notable that neither CiaC (CJM1_1224)
nor CiaD (CJM1_0764) were detected in the SILAC data set. However,
both proteins were detected in both WT and ﬂgG supernatants in the
label-free LC/MS data set. Detection of proteins within the LC/MS but
not the SILAC dataset may represent an incomplete incorporation of ex-
ogenous arginine labelling, as the external addition of “heavy” or “light”
arginine is the only difference between media used for the SILAC and
label-free LC/MS experiments and highlights the importance of
unlabelled LC/MS to account for this possibility. This may also account
for the lack of CiaD detection within the SILAC dataset as the protein
contains a single arginine. Previouswork has shown that Cia expression
and secretion is increased in the presence of external stimuli [25,26]. An
excellent future use of SILACwould be to compare supernatants isolated
from bacteria in the presence or absence of a stimulus such as bile salts.
This would enable a quantitative measurement of the effect of stimuli
on Cia secretion, andmay facilitate the identiﬁcation of further proteins,
part of the Cia family or otherwise, which contribute to C. jejuni human
tissue culture cell interaction.
Fig. 4.Mutations in genes previously characterized to be secreted via theﬂagellumandproteins identiﬁedby SILAC and label-free LC/MShave altered rates of (A) adhesion and (B) invasion
of CACO-2 cells. M1 WT cell interaction was set at 100%, * denotes strains with a P value b0.05 compared to M1WT.
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Immunoblotting of each of these FLAG-tagged proteins reﬂected the
levels observed in either the SILAC or label-free LC/MS data sets.
The dependence of CJM1_0791 and CJM1_0395 on the ﬂagellum for
their presence in the supernatant is to our knowledge the ﬁrst time that
this has been reported. CJM1_0791 is a putative periplasmic lipoprotein.
Disruption of CJM1_0791 led to a reduction in both rates of adhesion and
invasion (Fig. 4). The decreased adherence of the CJM1_0791mutant, its
status as a putative lipoprotein, and its relatively largemolecularweight
(48.9 kDa), make it possible that its absence within ﬂgG supernatants is
an indirect effect of knocking out the ﬂagellum. The disruption of a large
trans-membrane bound organelle, such as the ﬂagellum, could feasibly
lead to membrane structural alteration and a reduction in the presence
of other proteins predicted to be membrane bound such as CJM1_0791.
Further studies will be necessary to observewhether the protein actual-
ly passes through the ﬂagellum, or to identify what secondary effects
resulting from ﬂagellar disruption result in its absence from the super-
natant. In fact, it was noted that a small number of proteins, whichFig. 5. 81–176 homologues of CJM1_0791 and CJM1_0395 are dependent on the ﬂagellum
for their presence in 81–176 supernatant. Immunoblotting of FLAG-tagged proteins
exhibit the effect of an ﬂgG mutant on protein abundance present in supernatant and
whole cell protein samples obtained from strain 81–176.one would not expect to be secreted, were consistently reduced in
their abundancewithin the SILAC dataset from theM1 ﬂgG supernatants
(Fig. 2). Similar ﬁndings have occurred when using SILAC to study the
secretomes of other bacteria, such as the ribosomal protein L21 being
present in the SPI-2 (Salmonella Pathogenicity Island 2) dependent
secretome of S. enterica [23]. The presence of CysM within both WT
and ﬂgG supernatants was a surprising observation considering its use
as a marker for cell lysis in the past [13]. It is clear from the data
shown here that CysM is foundwithinM1 and 81–176 supernatants, al-
though the reasoning for this is unclear. Future studieswill be needed to
determine whether CysM is found within the supernatants of more C.
jejuni strains, as has been observed here for M1 and 81–176.
CJM1_0395 (26 kDa) is a member of the SprA-related superfamily of
zinc metalloproteases, and represents a good candidate as a novel
non-ﬂagellar protein secreted via the FT3SS. Another zinc
metalloprotease, NleC, present in E. coli and S. enterica and exported
via the T3SS also does not have a large effect on rates of epithelial cell
invasion as observed for a CJM1_0395mutant, but impairs anNF-kBme-
diated inﬂammatory response during infection [27–29]. Although there
is no sequence similarity between the two proteins, future work will be
required to address whether CJM1_0395 is delivered to host cells, and
whether it may contribute to aspects of C. jejuni disease other than a di-
rect inﬂuence on rates of adhesion/invasion of in vitro grown tissue cul-
ture cells.
In conclusion, in this studywe have applied quantitative proteomics
to study the C. jejuni ﬂagellum-dependent secretome quantitatively for
the ﬁrst time. The combination of SILAC and unlabelled proteomics has
led to the identiﬁcation of two proteins, CJM1_0791 and CJM1_0395,
which appear dependent on a WT ﬂagellum for their presence within
C. jejuni supernatant, representing putative effector proteins that regu-
late infection. We have also further deﬁned the inﬂuence of the ﬂagel-
lum on CiaI and FlaC secretion for C. jejuni strain M1, and identiﬁed
novel genes that alter the ability ofM1 to interactwith CACO-2 cells. Fu-
ture work combining the use of existing and developing proteomic
technologies will allow for a signiﬁcantly more in-depth assessment of
C. jejuni biology and host-pathogen interactions.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jprot.2016.11.009.Conﬂict of interest
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